Search Results

Futility stopping in clinical trials, optimality and practical considerations

• Authors : Yen Chang; Anastasia Ivanova; Tianhao Song

Subjects: Clinical Trials as Topic; 03 medical and health sciences; 0302 clinical medicine

• Source: Journal of Biopharmaceutical Statistics. 30:1050-1059

Record details

A novel evaluation of optimality for randomized controlled trials

• Authors : Scott M. Berry; Byron J. Gajewski; Christine M. Daley

Subjects: 03 medical and health sciences; 0302 clinical medicine; Research Design

• Source: Journal of Biopharmaceutical Statistics. 27:659-672

Record details

Comparison of Two Design Optimality Criteria Applied to a Nonlinear Model

• Authors : Barbara Bogacka; Francis J. Wright

Subjects: Nonlinear Dynamics; Research Design; 0502 economics and business

• Source: Journal of Biopharmaceutical Statistics. 14:909-930

Record details

An Effective Approach for Obtaining Optimal Sampling Windows for Population Pharmacokinetic Experiments

• Authors : Ogungbenro, Kayode; Aarons, Leon

Subjects: D-optimality; Optimal design; Blood Specimen Collection

• Source: Ogungbenro, K & Aarons, L 2009, 'An effective approach for obtaining optimal sampling windows for population pharmacokinetic experiments', Journal of Biopharmaceutical

Record details

Futility stopping in clinical trials, optimality and practical considerations.

• Authors : Chang, Yen; Song, Tianhao; Monaco, Jane

Subjects: FRUSTRATION; CLINICAL trials; CROSSOVER trials

• Source: Journal of Biopharmaceutical Statistics; 2020, Vol. 30 Issue 6, p1050-1059, 10p, 4 Charts, 1 Graph

Record details

Optimal Serial Dilutions Designs for Drug Discovery Experiments

• Authors : Donev, Alexander N.; Tobias, Randall D.

Subjects: Minimum significant difference; Dose-response study; Dose-Response Relationship, Drug

• Source: Donev, A N & Tobias, R D 2011, 'Optimal serial dilutions designs for drug discovery experiments', Journal of Biopharmaceutical Statistics, vol. 21, no. 3, pp. 484-497.

Record details

A novel evaluation of optimality for randomized controlled trials.

• Authors : Wick, Jo; Berry, Scott M.; Yeh, Hung-Wen

Subjects: BAYESIAN analysis; PROBABILITY theory; DATA envelopment analysis

• Source: Journal of Biopharmaceutical Statistics; 2017, Vol. 27 Issue 4, p659-672, 14p, 1 Diagram, 4 Charts, 3 Graphs

Record details

Optimal Design Criteria for Discrimination and Estimation in Nonlinear Models

• Authors : Waterhouse, T. H.; Eccleston, J. A.; Duffull, S. B. ...

Subjects: Optimal design; Pharmacology; Nonlinear model

• Source: Journal of Biopharmaceutical Statistics. 19:386-402

Record details

Compound Optimal Design Criteria for Nonlinear Models

• Authors : McGree, J. M.; Eccleston, J. A.; Duffull, S. B. ...

Subjects: D-optimality; P-optimality; Nonlinear models

• Source: Journal of Biopharmaceutical Statistics. 18:646-661

Record details

An optimal response adaptive design for multi-treatment clinical trials with ordinal categorical outcomes.

• Authors : Das, Soumyadeep¹ (AUTHOR); Bhattacharya, Rahul² (AUTHOR) ; Biswas, Atanu³ (AUTHOR)

• Source: Journal of Biopharmaceutical Statistics. 2021, Vol. 31 Issue 6, p809-827. 19p. 10 Charts, 5 Graphs.

Record details